Salvo Health
Subscription-based digital health for fatty liver
Medical Assistant
About the job
- Proven experience as a medical assistant, virtual medical assistant, or administrative support professional in a healthcare setting.
- Experience working in a remote setting.
- Experience making outbound calls to patients.
- Strong familiarity with electronic health record systems such as Epic, eCW, or gGastro.
- Experience with message triage, charting, or medical documentation.
- Ability to communicate effectively in writing and verbally with patients and care-team members.
- Ability to organize and manage time effectively.
- Ability to work independently and handle multiple tasks efficiently.
- Conduct outbound calls to patients to complete patient intake calls.
- Manage patient scheduling, appointments, and follow-ups.
- Handle medical records, data entry, and documentation in electronic health record systems.
- Monitor, triage, and respond to incoming member messages.
- Ensure that patient records are accurately entered into the electronic health record system and update them as needed.
- Ensure compliance with HIPAA regulations and maintain patient confidentiality.
- Provide general administrative support to the care team and patients.
- Manage patient tasks to ensure timely documentation and communication for all patients.
- Experience working with gastrointestinal conditions.
- Familiarity with telemedicine platforms.
About the company
Salvo Health provides digital health services for metabolic liver diseases, mainly fatty liver disease. It runs a remote patient monitoring (RPM) platform that lets patients with conditions like MASLD and MASH stay connected with their care team via text, enabling real-time health management without frequent in-person visits. The service is delivered through a subscription model that includes personalized care plans and continuous access to clinicians, with potential reimbursements or partnership fees from payers and practices. How it differs from competitors is its focus on real-time, text-based communication and ongoing, personalized care for chronic liver and gut conditions via RPM, rather than one-off visits or generic digital programs. The company’s goal is to improve patient outcomes and satisfaction by making specialized liver-care more accessible, timely, and tailored to each patient’s needs.
Company Size
51-200
Company Stage
Series A
Total Funding
$28M
Headquarters
New York City, New York
Founded
2021
Get referred to Salvo Health
See people who can refer or advise you
Simplify's Take
What believers are saying
- Salvo reported 800% patient and revenue growth in 2025, still cited in 2026.
- Its August 2026 blog says 700 GI physicians signed, covering 14% of independents.
- Pinnacle GI Partners expanded Salvo in Michigan, proving adoption inside large local practices.
What critics are saying
- Oshi, Ayble, and Vivante crowd the same virtual GI care market.
- Salvo's reimbursement story depends on payer contracts; direct consumer subscription economics stay fragile.
- If specialty practices adopt in-house teams, Salvo loses distribution and dies.
What makes Salvo Health unique
- Salvo embeds dietitians, nurses, and behavioral health into existing GI practices.
- January 2026 Series A backing from ManchesterStory, City Light, and Threshold validates the model.
- It targets independent gastroenterologists, not consumers, with 700-plus partners by August 2026.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Remote Work Options
Flexible Work Hours
Professional Development Budget
Growth & Insights and Company News
6 month growth
↑ 3%1 year growth
↓ -1%2 year growth
↑ 0%Salvo Health has raised $8.5 million in a Series A round led by ManchesterStory, City Light Capital and Threshold Ventures, following 800% revenue growth last year. The company provides wraparound support for independent gastroenterology practices rather than competing with them directly. The platform has signed 801 gastroenterologists, representing 16% of independent US practices. It offers patients access to registered dietitians, behavioural health specialists and nurses through AI-enabled continuous care that integrates with existing clinics. The hybrid model has delivered a 79% reduction in GI-related emergency room utilisation. Salvo addresses a fragmented market serving 100 million Americans with gastrointestinal issues, providing ongoing support for diet, stress management and medication adherence that independent practices typically cannot staff full-time.
Salvo Health raises $8.5M in Series A funding. Salvo Health, a New York-based provider of a virtual care platform specializing in gastrointestinal and metabolic health, raised $8.5m in Series A funding. The round was co-led by ManchesterStory, City Light Capital, and Threshold Ventures, with participation from new investors The Artemis Fund, Contour Venture Partners, Owl Capital, and Impact X Capital Partners, and existing investors Human Ventures, Torch Capital, Felicis Ventures, and Alumni Ventures. The company intends to use the funds to expand its engineering team for an AI-led roadmap and increase the national hiring of registered dietitians, behavioral health professionals, and nurses to meet rising patient demand. Led by CEO Jeffrey Glueck, COO Marin Rothenberg, and CMO Dr. Erin Hendriks, Salvo Health provides brick & mortar clinics with a continuous care platform that enables users to save time, increase revenue, and improve patient outcomes by offering direct access to a gut-focused care team. In 2025, the company has grown patients and revenue by 800% YoY and enterprise agreements with GI doctors by more than 1,000%. Salvo has also signed agreements with 801 GIs.
Salvo Health announces $4 million in new funding.
Salvo Health raised $4M in an extended Seed Prime round, following a $5M investment last year. The funds will expand its clinical team and virtual care platform across GI partner clinics with 700 physicians. The company, which launched in 2022 with $10.5M funding, has seen an 800% rise in patient volume and aims to grow revenue sixfold by year-end. New investor The Artemis Fund joined existing investors in this round.
Alumni Ventures invests in Salvo Health to revolutionize chronic condition management.